Adams DM, Ricci KW (2018) Infantile hemangiomas in the head and neck region. Otolaryngol Clin North Am 51:77–87. https://doi.org/10.1016/j.otc.2017.09.009

Article  PubMed  Google Scholar 

Ahmed I, Berth-Jones J (2000) Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol 143:843–845. https://doi.org/10.1046/j.1365-2133.2000.03787.x

Article  CAS  PubMed  Google Scholar 

Ahn M-Y, Kwon S-M, Cheong HH et al (2012) Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis. J Oral Pathol Med off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 41:540–546. https://doi.org/10.1111/j.1600-0714.2012.01158.x

Article  CAS  Google Scholar 

Aspord C, Tramcourt L, Leloup C et al (2014) Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization. J Invest Dermatol 134:2551–2561. https://doi.org/10.1038/jid.2014.194

Article  CAS  PubMed  Google Scholar 

Beresford MJ, Wilson GD, Makris A (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res BCR 8:216. https://doi.org/10.1186/bcr1618

Article  PubMed  Google Scholar 

Beutner KR, Spruance SL, Hougham AJ et al (1998) Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 38:230–239. https://doi.org/10.1016/s0190-9622(98)70243-9

Article  CAS  PubMed  Google Scholar 

Colmant C, Powell J (2022) Medical management of infantile hemangiomas: an update. Paediatr Drugs 24:29–43. https://doi.org/10.1007/s40272-021-00477-9

Article  PubMed  Google Scholar 

Craiglow BG, Antaya RJ (2013) Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatr Drugs 15:133–138. https://doi.org/10.1007/s40272-013-0008-6

Article  PubMed  Google Scholar 

Dahl MV (2002) Imiquimod: a cytokine inducer. J Am Acad Dermatol 47:S205-208. https://doi.org/10.1067/mjd.2002.126586

Article  PubMed  Google Scholar 

Drolet BA, Frommelt PC, Chamlin SL et al (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131:128–140. https://doi.org/10.1542/peds.2012-1691

Article  PubMed  PubMed Central  Google Scholar 

Greenberger S, Bischoff J (2013) Pathogenesis of infantile haemangioma. Br J Dermatol 169:12–19. https://doi.org/10.1111/bjd.12435

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartzell LD, Buckmiller LM (2012) Current management of infantile hemangiomas and their common associated conditions. Otolaryngol Clin North Am 45:545–556, vii. https://doi.org/10.1016/j.otc.2012.03.001

Article  PubMed  Google Scholar 

Hazen PG, Carney JF, Engstrom CW et al (2005) Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 22:254–256. https://doi.org/10.1111/j.1525-1470.2005.22318.x

Article  PubMed  Google Scholar 

Hengge UR, Stark R (2001) Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 137:709–711

CAS  PubMed  Google Scholar 

Ho NTC, Lansang P, Pope E (2007) Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 56:63–68. https://doi.org/10.1016/j.jaad.2006.06.011

Article  PubMed  Google Scholar 

Jacobs AH (1957) Strawberry hemangiomas—the natural history of the untreated lesion. Calif Med 86:8–10

CAS  PubMed  PubMed Central  Google Scholar 

Jiang C, Hu X, Ma G et al (2011) A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma. Pediatr Dermatol 28:259–266. https://doi.org/10.1111/j.1525-1470.2011.01520.x

Article  PubMed  Google Scholar 

Junkins-Hopkins JM (2009) Imiquimod use in the treatment of lentigo maligna. J Am Acad Dermatol 61:865–867. https://doi.org/10.1016/j.jaad.2009.08.023

Article  PubMed  Google Scholar 

Kuznetsova SA, Starikova EA, Freidlin IS, Smirnov VS (2012) In vitro studies of changes in human endothelial cell functions under the effect of imiquimod. Bull Exp Biol Med 154:237–240. https://doi.org/10.1007/s10517-012-1921-3

Article  CAS  PubMed  Google Scholar 

Liu X, Qu X, Zheng J, Zhang L (2015) Effectiveness and safety of oral propranolol versus other treatments for infantile hemangiomas: a meta-analysis. PLoS One 10:e0138100. https://doi.org/10.1371/journal.pone.0138100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marks R, Gebauer K, Shumack S et al (2001) Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 44:807–813. https://doi.org/10.1067/mjd.2001.113689

Article  CAS  PubMed  Google Scholar 

Martinez MI, Sanchez-Carpintero I, North PE, Mihm MC (2002) Infantile hemangioma: clinical resolution with 5% imiquimod cream. Arch Dermatol 138:881–884. https://doi.org/10.1001/archderm.138.7.881. discussion 884

Article  PubMed  Google Scholar 

McCuaig CC, Dubois J, Powell J et al (2009) A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 26:203–212. https://doi.org/10.1111/j.1525-1470.2008.00857.x

Article  PubMed  Google Scholar 

McInturff JE, Modlin RL, Kim J (2005) The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125:1–8. https://doi.org/10.1111/j.0022-202X.2004.23459.x

Article  CAS  PubMed  Google Scholar 

Miller R (2002) Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors. Int J Dermatol 41(Suppl 1):3–6. https://doi.org/10.1111/j.1365-4632.2002.00017.x

Article  CAS  PubMed  Google Scholar 

Qiu Y, Ma G, Lin X et al (2013) Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars. Pediatr Dermatol 30:342–347. https://doi.org/10.1111/pde.12002

Article  PubMed  Google Scholar 

Razon MJ, Kräling BM, Mulliken JB, Bischoff J (1998) Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirc N Y N 1994 5:189–195

CAS  Google Scholar 

Rocco R, Alegre N, Pozner R et al (2018) Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod. Toxicol Lett 288:82–88. https://doi.org/10.1016/j.toxlet.2018.01.016

Article  CAS  PubMed  Google Scholar 

Sauder DN (2000) Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 43:S6-11. https://doi.org/10.1067/mjd.2000.107808

Article  CAS  PubMed  Google Scholar 

Senchak AJ, Dann M, Cable B, Bessinger G (2010) Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases. Ear Nose Throat J 89:E21-25

PubMed  Google Scholar 

Sidbury R, Neuschler N, Neuschler E et al (2003) Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol 121:1205–1209. https://doi.org/10.1046/j.1523-1747.2003.12521.x

Article  CAS  PubMed  Google Scholar 

Spyratos F, Ferrero-Poüs M, Trassard M et al (2002) Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer 94:2151–2159. https://doi.org/10.1002/cncr.10458